Tumour-initiating cells: challenges and opportunities for anticancer drug discovery. - Wikidata - wikimedia - TriplyDB

Tumour-initiating cells: challenges and opportunities for anticancer drug discovery.

Tumour-initiating cells: challenges and opportunities for anticancer drug discovery.

http://www.wikidata.org/entity/Q37606286

about

Salinomycin as a drug for targeting human cancer stem cells Phosphorylation of EZH2 activates STAT3 signaling via STAT3 methylation and promotes tumorigenicity of glioblastoma stem-like cells Modulation of T-cell activation by malignant melanoma initiating cells ABCB5 identifies a therapy-refractory tumor cell population in colorectal cancer patients Nutritional and Nanotechnological Modulators of Microglia Yin Yang 1 is associated with cancer stem cell transcription factors (SOX2, OCT4, BMI1) and clinical implication The Dark Side of Cell Fusion Redox Modulating NRF2: A Potential Mediator of Cancer Stem Cell Resistance Polyphenols as Modulator of Oxidative Stress in Cancer Disease: New Therapeutic Strategies Bone metastases: When and how lung cancer interacts with bone Technologies for deriving primary tumor cells for use in personalized cancer therapy Cancer nanotheranostics: improving imaging and therapy by targeted delivery across biological barriers.Regulation of ovarian cancer stem cells or tumor-initiating cells Modeling human endothelial cell transformation in vascular neoplasias Emerging therapeutic biomarkers in endometrial cancer Brain tumor stem cells: Molecular characteristics and their impact on therapy Antibody Drug Conjugates: Preclinical Considerations Adult pituitary stem cells: from pituitary plasticity to adenoma development Contemporary murine models in preclinical astrocytoma drug development Dietary Sulforaphane in Cancer Chemoprevention: The Role of Epigenetic Regulation and HDAC Inhibition High-Throughput Single-Cell Derived Sphere Formation for Cancer Stem-Like Cell Identification and Analysis.Non-invasive in vivo imaging of tumor-associated CD133/prominin Phage display discovery of novel molecular targets in glioblastoma-initiating cells Codelivery of salinomycin and doxorubicin using nanoliposomes for targeting both liver cancer cells and cancer stem cells The impact of low-dose carcinogens and environmental disruptors on tissue invasion and metastasis Norcantharidin, derivative of cantharidin, for cancer stem cells Breast cancer stem-like cells are inhibited by a non-toxic aryl hydrocarbon receptor agonist Galiellalactone inhibits stem cell-like ALDH-positive prostate cancer cells Gene expression profiling of liver cancer stem cells by RNA-sequencing EGFR inhibition abrogates leiomyosarcoma cell chemoresistance through inactivation of survival pathways and impairment of CSC potential Response of breast cancer cells and cancer stem cells to metformin and hyperthermia alone or combined Elevated expression of AKR1C3 increases resistance of cancer cells to ionizing radiation via modulation of oxidative stress Different Effects of BORIS/CTCFL on Stemness Gene Expression, Sphere Formation and Cell Survival in Epithelial Cancer Stem Cells Drosophila Wnt and STAT Define Apoptosis-Resistant Epithelial Cells for Tissue Regeneration after Irradiation Reverse Chemical Genetics: Comprehensive Fitness Profiling Reveals the Spectrum of Drug Target Interactions µFBI: a microfluidic bead-based immunoassay for multiplexed detection of proteins from a µL sample volume EMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancer Mitochondrial control by DRP1 in brain tumor initiating cells.Improving the radiosensitivity of radioresistant and hypoxic glioblastoma.Functional analysis of HOXD9 in human gliomas and glioma cancer stem cells

P2860

Q21285139-D625700F-111C-4CD3-8BBC-A5DA570D2557 Q24293124-CFF471B1-2249-452E-A1F4-033F4E2C25F8 Q24595394-93846FFD-7B20-4892-BA95-68157ABC9535 Q24632539-3AFF13A0-7587-416A-950F-EFF63E569BE5 Q26740644-5326EA98-3E01-4180-B0CE-2378EB12F004 Q26745972-B3689C63-F1D3-48A2-9E5B-17391AFF4B3F Q26748224-4229E21E-B29B-476A-9F16-DD4680FB6C47 Q26774916-57E4AFCE-AD7C-4809-A859-D6506234E3A3 Q26822819-C19E8CE2-E5E4-446A-B179-CE4DAD4B8B7A Q26823287-53DF23E5-4027-40F9-89C8-08288750F4CE Q26829581-913A0B00-A7D8-4AF1-B873-4DA2384B1A70 Q26830028-113A1636-E114-474B-8514-9547699BF464 Q26853096-C7CB3F84-3024-4723-8328-F4450082AC90 Q26860203-85CB292C-A646-43EB-84E7-1C158B0AF901 Q26865904-F48D95E0-F6C4-4005-894C-C9BE7CC4D59D Q27003138-7DC92ACF-6B97-432C-A23B-6A69B7A4FC36 Q27022321-B1B83AA9-BDBD-4249-9ABA-7936963D2C37 Q27024298-32893F1C-AD88-49E6-99BC-7770AB01B7DE Q27026937-0797BDB4-71B8-4C99-A7A4-FBCBCDA726AD Q27026986-2FD633E7-631D-45A6-96BF-71A3C1005FD5 Q27346354-E4F441BC-CA1D-4247-8F1E-5316704BEDDC Q27438105-9890F295-A2D6-4E93-B52B-24C853C036AB Q28240138-CE08C34C-764C-4C91-96D7-00AC997FDE04 Q28315452-77ECA008-C3FF-4351-B578-2418A706750F Q28388257-31DA6510-F643-4B88-98B1-DC4643421855 Q28388647-43DB44DE-786B-4879-846C-2B00630BF7D9 Q28475994-77E411FA-E236-4A44-A397-D77905BDF6BB Q28478976-2CB59B2D-DB89-48B2-9C91-9F058D82EDF9 Q28483663-E3F63F7F-589D-48DC-8149-6BFE2E16E0D0 Q28484249-250D0872-E616-42DF-A213-ADB75491B4D2 Q28539523-A7CC6041-E91A-4F57-9439-66070375FB56 Q28545132-4EF5E155-ED1D-4FED-AF62-CCCDE9801484 Q28546641-1AB19FF9-0565-4E17-86D8-83016731FDB3 Q28553817-677E0A88-0762-41D1-9AF4-54D9BA3CCF0F Q28553891-06752EB6-6003-4E6E-BC37-445DD6E49739 Q28749053-3505D220-A3D6-43FA-9E3E-D56DF402D21E Q29616360-E3E80C8B-FBDB-463B-ACEE-6B0ECD45A147 Q30300490-E1631BE6-085E-4668-8120-589775FCDC8B Q30452219-BD98DD0C-C8D7-4623-8FC7-AB2CFA734DDD Q30501326-2A6FC51C-855B-4BED-AB20-E12F1C5EEDFB

P2860

Tumour-initiating cells: challenges and opportunities for anticancer drug discovery.

http://www.wikidata.org/entity/Q37606286

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on October 2009

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Tumour-initiating cells: challenges and opportunities for anticancer drug discovery.

@en

Tumour-initiating cells: challenges and opportunities for anticancer drug discovery.

@nl

type

label

Tumour-initiating cells: challenges and opportunities for anticancer drug discovery.

@en

Tumour-initiating cells: challenges and opportunities for anticancer drug discovery.

@nl

prefLabel

Tumour-initiating cells: challenges and opportunities for anticancer drug discovery.

@en

Tumour-initiating cells: challenges and opportunities for anticancer drug discovery.

@nl

P1433

Q37606286-7327A0B4-E1D4-4DFF-BCD4-AFD2103C2029

P1476

Q37606286-05134FB8-2E91-45B5-B6D5-18A766332F58

P2093

Q37606286-3E3FF1FA-645E-44FF-917B-04896ED5520A

Q37606286-6DBBC724-DC66-4F01-887B-60C19E7BE030

Q37606286-8BEB0F4C-D480-44E8-BD3E-61BDCD1E6359

Q37606286-927D798F-344B-4459-8933-BF464B2FF9B9

Q37606286-AB9CEA86-4D90-4EF0-90BB-E33AAEE7AF80

Q37606286-F45104AC-4B2E-4B5C-BF48-58BE23BB2364

P2860

Q37606286-0D033EB3-0AEE-48ED-8B7F-ED1A77738673

Q37606286-502DC643-1477-41E7-8A39-B2CBA143DF55

Q37606286-CB1093C3-185C-45EB-8A1D-46D2DF27620E

Q37606286-EC5C7E97-0A42-495C-8084-5FB24CC2737B

P2888

Q37606286-D6EC8F3A-F89C-4B31-AF93-3ED77553E53B

P304

Q37606286-DA25B83A-B37D-42AE-8F6B-B0955EEE145F

P31

Q37606286-058E7117-4EB1-4D0E-8ABB-9FAAD28E3A5D

P356

Q37606286-DDDA2391-605E-4BB2-B8EA-FB31925E6732

P433

Q37606286-13F36FB0-C817-4231-99DB-4EDF50FB4178

P478

Q37606286-33578F05-14C2-40D3-9935-A25A31D704E7

P577

Q37606286-AB99967A-4C0C-48E5-B2F4-49568F408649

P5875

Q37606286-00A56533-3A8E-4BE2-A3A5-5396D42CFE09

P6179

Q37606286-3331D14C-ED9E-4289-9DE4-AC61B1448A89

P698

Q37606286-30A231F5-66A5-41A3-ABA5-512D37CDB783

P356

P1433

Nature Reviews Drug Discovery

P1476

Tumour-initiating cells: challenges and opportunities for anticancer drug discovery.

@en

P2093

Bin-Bing S Zhou

http://www.w3.org/2001/XMLSchema#string

Haiying Zhang

http://www.w3.org/2001/XMLSchema#string

Justin C Grindley

http://www.w3.org/2001/XMLSchema#string

Kenneth G Geles

http://www.w3.org/2001/XMLSchema#string

Marc Damelin

http://www.w3.org/2001/XMLSchema#string

Peter B Dirks

http://www.w3.org/2001/XMLSchema#string

P2860

Environmental restrictions within tumor ecosystems select for a convergent, hypoxia-resistant phenotype of cancer stem cells.

beta-Catenin and TGFbeta signalling cooperate to maintain a mesenchymal phenotype after FosER-induced epithelial to mesenchymal transition.

Three-dimensional tissue cytometer based on high-speed multiphoton microscopy.

Pathways to tumorigenesis--modeling mutation acquisition in stem cells and their progeny.

P2888

P304

806-823

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/NRD2137

http://www.w3.org/2001/XMLSchema#string

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

8

http://www.w3.org/2001/XMLSchema#string

P577

2009-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

26861053

http://www.w3.org/2001/XMLSchema#string

P6179

1047880637

http://www.w3.org/2001/XMLSchema#string

P698

19794444

http://www.w3.org/2001/XMLSchema#string